Terms ending in 2033
Every in-force patent on AbbVie Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,006,247 | Apoptosis-Inducing Agents for the Treatment of Cancer and Immune and Autoimmune Diseases In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US D807,923 | Interface Portion of a Pump In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 9,102,722 | Composition and Method for the Diagnosis and Treatment of Diseases Associated with Neurite Degeneration Müller, Bernhard Klaus, DR. In force · Low confidence | Müller, Bernhard Klaus, DR. | In force | Low confidence | |
| US 9,365,643 | Antibodies That Bind to Repulsive Guidance Molecule a (RGMA) Müller, Bernhard Klaus, DR. In force · Medium confidence | Müller, Bernhard Klaus, DR. | In force | Medium confidence | |
| US 10,106,602 | Isolated Monoclonal Anti-Repulsive Guidance Molecule a Antibodies and Uses Thereof Müller, Bernhard Klaus, DR. In force · Medium confidence | Müller, Bernhard Klaus, DR. | In force | Medium confidence | |
| US D810,278 | Injector Device In force · High confidence | AbbVie Biotechnology Ltd. (Puerto Rico Branch) | In force | High confidence | |
| US D810,279 | Injector Device In force · High confidence | AbbVie Biotechnology Ltd. (Puerto Rico Branch) | In force | High confidence | |
| US 9,447,051 | Diaminopyrimidines And Uses Thereof In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 8,986,972 | Nucleic Acid Encoding DLL3 Antibodies In force · Medium confidence | AbbVie Stemcentrx LLC | In force | Medium confidence | |
| US 8,969,325 | TRPV1 Antagonists In force · High confidence | AbbVie Inc. | In force | High confidence | |
| 72 more term ends in 2033 · Pro | |||||
10 of 82 patents shown. Soonest term end first, then patent number.
Pro members see all 82.
78 of these are in force and held by AbbVie Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.